Detalhe da pesquisa
1.
Neuromodulation with aerobic exercise reduces fatigue in systemic lupus erythematosus: a randomised, sham-controlled, double-blind study.
Clin Exp Rheumatol
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451142
2.
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2.
Rheumatology (Oxford)
; 61(8): 3351-3361, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664616
3.
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine.
Rheumatology (Oxford)
; 62(1): 480-485, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639644
4.
Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases.
Brain Behav Immun
; 101: 49-56, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954325
5.
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose.
Clinics (Sao Paulo)
; 78: 100150, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529052
6.
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study.
Lancet HIV
; 9(5): e323-e331, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338835
7.
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus.
Arthritis Care Res (Hoboken)
; 74(4): 562-571, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806342
8.
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study.
Lancet Rheumatol
; 4(2): e113-e124, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34901885
9.
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients.
J Appl Physiol (1985)
; 132(3): 682-688, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35142560
10.
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients.
Nat Commun
; 13(1): 5801, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192386
11.
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.
Nat Med
; 27(10): 1744-1751, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331051
12.
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose
Clinics
; 78: 100150, 2023. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1421262